John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cloudflare
NET
|
+$299M |
| 2 |
Advanced Micro Devices
AMD
|
+$249M |
| 3 |
Pfizer
PFE
|
+$227M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$212M |
| 5 |
NVIDIA
NVDA
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$241M |
| 2 |
Cisco
CSCO
|
+$234M |
| 3 |
Analog Devices
ADI
|
+$198M |
| 4 |
Mondelez International
MDLZ
|
+$185M |
| 5 |
Philip Morris
PM
|
+$182M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.01% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 10.3% |
| 4 | Industrials | 9.92% |
| 5 | Financials | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
4226
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-362,204
| Closed | -$11.9M |
|
4227
CALL
Alpha Pro Tech
APT
$54.4M
| – | – |
-21,600
| Closed | -$145K |
|
4228
Apyx Medical
APYX
$131M
| – | – |
-26,643
| Closed | -$369K |
|
4229
ArcBest
ARCB
$3.04B
| – | – |
-16,162
| Closed | -$1.32M |
|
4230
Arcturus Therapeutics
ARCT
$446M
| – | – |
-7,444
| Closed | -$356K |
|
4231
Ardelyx
ARDX
$984M
| – | – |
-850,970
| Closed | -$1.12M |
|
4232
Archrock
AROC
$5.41B
| – | – |
-10,522
| Closed | -$87K |
|
4233
CALL
Array Technologies
ARRY
$704M
| – | – |
-16,700
| Closed | -$309K |
|
|
4234
PUT
Array Technologies
ARRY
$704M
| – | – |
-27,400
| Closed | -$507K |
|
4235
Associated Banc-Corp
ASB
$5.81B
| – | – |
-178,723
| Closed | -$3.83M |
|
4236
AerSale
ASLE
$267M
| – | – |
-16,821
| Closed | -$286K |
|
4237
AdvanSix
ASIX
$441M
| – | – |
-11,204
| Closed | -$445K |
|
4238
Aterian
ATER
$7.74M
| – | – |
-37,533
| Closed | -$2.78M |
|
4239
Atkore
ATKR
$3.16B
| – | – |
-3,755
| Closed | -$326K |
|
|
FRMM
4240
Forum Markets
FRMM
$77.9M
| – | – |
-4
| Closed | -$75K |
|
4241
Atomera
ATOM
$178M
| – | – |
-72,395
| Closed | -$1.7M |
|
4242
Atara Biotherapeutics
ATRA
$96.8M
| – | – |
-9,845
| Closed | -$4.41M |
|
4243
AtriCure
ATRC
$2.47B
| – | – |
-66,280
| Closed | -$4.61M |
|
4244
Avista
AVA
$3.18B
| – | – |
-6,701
| Closed | -$262K |
|
|
DCH
4245
CALL
Dauch Corp
DCH
$1.52B
| – | – |
-15,200
| Closed | -$134K |
|
|
DCH
4246
Dauch Corp
DCH
$1.52B
| – | – |
-135,271
| Closed | -$1.19M |
|
4247
Axalta
AXTA
$7.76B
| – | – |
-171,133
| Closed | -$5.43M |
|
4248
CALL
Acuity Brands
AYI
$10.1B
| – | – |
-4,300
| Closed | -$745K |
|
|
4249
PUT
Acuity Brands
AYI
$10.1B
| – | – |
-5,000
| Closed | -$867K |
|
4250
Azenta
AZTA
$1.44B
| – | – |
-96,421
| Closed | -$9.87M |
|
Similar funds
John Overdeck's Q4 2021 Portfolio in Review
As of Q4 2021, John Overdeck held 5,171 positions worth $46.8B, up 4.6% from $44.7B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
John Overdeck's Q4 2021 filing shows 995 new, 1,525 increased, 1,628 reduced and 977 closed positions. Its largest new stake was Cloudflare: 1,781,661 shares worth $234M. The largest sale was Lam Research, an estimated $241M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- John Overdeck's largest Q4 2021 buy was Cloudflare: 1,781,661 shares worth $234M.
- John Overdeck added most to Advanced Micro Devices in Q4 2021, an estimated $249M increase.
- John Overdeck's biggest Q4 2021 reduction was Mondelez International, cutting an estimated $185M.
- John Overdeck fully exited Lam Research in Q4 2021, selling an estimated $241M.
- John Overdeck's ten largest holdings make up 5.7% of its $46.8B portfolio in Q4 2021.
- John Overdeck opened 995 new positions and closed 977 in Q4 2021.
- John Overdeck's portfolio value rose 4.6% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q4 2021, filed 14 Feb 2022.